A UC Riverside-led study focusing on an oncoprotein called MYC has discovered a new MYC signaling mechanism that is deregulated in cancer cells. This mechanism, called MYC lysine-acetylation, activates specific genes that make mammary cells malignant and drives the tumor-promoting functions of MYC, including the ability of cancer cells to survive and proliferate even without...
A multiyear cancer-research project, stemming from a newly established partnership between the University of California, Riverside, and the City of Hope – Comprehensive Cancer Center (CoH-CCC), has received funding from the National Cancer Institute (NCI) of the National Institutes of Health to develop collaborations, resources, and training programs aimed at reducing disparities in cancer research...
Congratulations to 6 (six) of UCR MARC Trainees who won best poster awards during ABRCMS 2020! MARC Award Recipient(s):Kimberly Bennett, Marco Duenas, Halee Scott, Jose Soto, Spencer Pak, and Abel Vargas
